Hospital Clínico Universidad de Chile
Santiago, International, 6677, Chile
NCT Number: NCT03573843
This study is a pilot randomized controlled trial, comparing a group of older patients with standardized non-pharmacological delirium prevention plus a basic tablet versus a group with standardized non-pharmacological delirium prevention plus a tablet with a software of cognitive stimulation (PREVEDEL).
Software:It is a local development, including a interprofessional team of delirium healthcare experts, older patients and a team og engineers. The software was developed during the first year of this project and was inscribed for author rights.
Inclusion criteria: Older patients > 65 y.o. Admitted to medicine room or intermediate care unit > 48 hrs, and informed consent to participate.
Exclusion Criteria:Delirium positive, neuroleptic use, dementia, and non-spanish speakers.
The study was approved by ethical committee of Hospital Clinico University of Chile Standardized Non-pharmacological intervention: Health workers were previously educated in delirium, and environmental issues were implemented. This intervention coverage in nine different domains: orientation, early mobilization, environmental noise and light, sensorial deficit, sleep, hydratation, drug reduction, and family participation.
Intervention: All patients will have a tablet with or without the software PREVEDEL between 09:00-19:00 hrs.
Measures: delirium will be monitoring with CAM (Confusion Assessment Method) twice a day for 5 days.
Primary outcome: Delirium rate between both groups Secondary outcomes:Long of stay, severity od delirium, time of use of electronic device, and Barthel to discharge.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Santiago, International, 6677, Chile
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Older patients > 65 y.o. Admitted to medicine room or intermediate care unit > 48 hrs, and informed consent to participate.
Exclusion criteria
Delirium positive, neuroleptic use, dementia, and non-spanish speakers.
All patients will have a tablet with the software PREVEDEL between 09:00-19:00 hrs.
All patients will have a tablet without the software PREVEDEL between 09:00-19:00 hrs.
Time frame: 5 days
Delirium will be assessed with CAM (the confusion assessment method) twice a day.
Time frame: 5 days
The days of total hospital stay of the patients will be recorded
Time frame: 5 days
Delirium will be evaluated with CAM-S (the confusion assessment method Severity) whenever appropriate.
Time frame: 5 days
The usage time on the mobile device (with internal device registration) will be recorded.
Time frame: 5 days
Functionality at discharge will be assessed with Barthel Index test at discharge.
University of Chile
Other
Cognitive Stimulation Guided by a Software to Prevent Delirium in Older Patients
Acronym: Prevedel
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04093219
Arterial Occlusive Diseases, Arteriosclerosis
Birmingham, Alabama, United States
View Trial DetailsNCT06176625
Behavior, Behavioral Symptoms
Baltimore, Maryland, United States
View Trial DetailsNCT06029244
Confusion, Critical Illness
Boston, Massachusetts, United States
View Trial DetailsNCT07119385
Confusion, Delirium
Badalona, Catalonia, Spain
View Trial Details